Profil
Mark Bechter is a Medical Director at Baxter BioScience Corp.
He previously worked as a Vice President-Medical Affairs at Amicus Therapeutics, Inc. and Spyre Therapeutics, Inc. He also served as the Chief Medical Officer at Precision Medicine Catapult.
Bechter holds a doctorate degree from The University of Southampton.
Postes actifs de Mark Bechter
| Sociétés | Poste | Début |
|---|---|---|
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Mark Bechter
| Sociétés | Poste | Fin |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Precision Medicine Catapult
Precision Medicine Catapult BiotechnologyHealth Technology Engages in research and development of biotechnology | Directeur Technique/Scientifique/R&D | - |
| SPYRE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Mark Bechter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Precision Medicine Catapult
Precision Medicine Catapult BiotechnologyHealth Technology Engages in research and development of biotechnology | Health Technology |
















